Oriental Spring Capital
Overview
Oriental Spring Capital is a Chinese investment firm established in 2015 that focuses on the new economy, with an emphasis on the consumption and cutting-edge technology industries.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Abogen Biosciences | Aug 2021 | Series C | Co-investor |
| Supermonkey | Feb 2019 | Series D | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Oriental Spring Capital based?
Oriental Spring Capital is headquartered in Beijing, China.
When was Oriental Spring Capital founded?
Oriental Spring Capital was founded in 2015.
How many portfolio companies does Oriental Spring Capital have?
Oriental Spring Capital has 2 portfolio companies in Caplight's dataset.
What are some companies in Oriental Spring Capital's portfolio?
Portfolio companies visible on Caplight include Abogen Biosciences, Supermonkey.
What was Oriental Spring Capital's most recent investment shown here?
Oriental Spring Capital's most recent investment in this portfolio sample was in Abogen Biosciences in 2021.
What sectors does Oriental Spring Capital focus on?
Oriental Spring Capital focuses on Consumer & Commerce, Healthcare & Life Sciences.
What company stages does Oriental Spring Capital focus on?
Oriental Spring Capital typically invests at the Mid stage.
What is Oriental Spring Capital's AUM?
Oriental Spring Capital's assets under management are estimated between $1.4B and $1.9B.